cPKC γ Inhibitors

Common cPKC γ Inhibitors include, but are not limited to Rottlerin CAS 82-08-6, Bisindolylmaleimide VIII CAS 138516-31-1, Gö 6983 CAS 133053-19-7, Ro 31-8220 CAS 138489-18-6 and Bisindolylmaleimide I (GF 109203X) CAS 133052-90-1.

Conventional Protein Kinase C (cPKC) is a subgroup within the Protein Kinase C (PKC) family, which consists of a range of serine/threonine kinases involved in many cellular signaling pathways. The cPKC subgroup comprises α, βI, βII, and γ isoforms. Among these, cPKC γ (or PKCγ) is of notable interest to researchers due to its specific involvement in various cellular processes. To modulate the activity of PKCγ, a series of compounds have been identified, known as cPKC γ inhibitors. These inhibitors selectively hinder the action of the PKCγ isoform, thereby impacting the downstream pathways it influences.

From a chemical perspective, cPKC γ inhibitors can be diverse in their structures. Their design usually focuses on targeting the ATP-binding site or the regulatory domains of the kinase, aiming for specificity over the PKCγ isoform. To achieve this specificity, researchers often use a combination of high-throughput screening, molecular docking, and structural biology insights. The ATP-binding site, being a common target, often involves inhibitors that are competitive with ATP, meaning they bind to the same site as ATP, preventing the kinase from using ATP in its phosphorylation reactions. However, achieving isoform-specific inhibition is challenging due to the high structural similarities among PKC family members. As a result, the development of these inhibitors necessitates a profound understanding of the subtle differences in isoform structures and a meticulous design to ensure selectivity towards PKCγ. This chemical and structural complexity underscores the importance and challenge of designing and developing cPKC γ inhibitors.